Access BayerPRO

<p>Stay up to date with exclusive content for Healthcare Professionals:</p><ul><li>Latest updates</li><li>Find useful tools for your practice</li><li>Access patient support materials</li></ul>

Sign up to BayerMED:

Register | Login For Further Access

404 Page

Awareness​

Learning Materials

MENOPAUSE

Clinical Tools 

CONTRACEPTION

Women's Health

Events

Medical Literature

PROSTATE CANCER

Oncology

Learning Materials 

Medical Literature 

CHRONIC KIDNEY DISEASE 

HEART FAILURE 

Cardio Renal 

Ophthalmology

Hematology

Home

OCEANIC-STROKE

New Findings

Third-Party Learning Material

Neurology

Bayer Logo

bottom

Womens Health.png

Menopause

Plain Blue Hero Banner.png

Other

small_Cardiovascular_32px.png

Heart Failure

small_Ophthalmology_32px.png

OCEANIC STROKE Publication

media:remote_media:56619757-a874-415c-a78d-d6337437d901

OCEANIC-STROKE Publication

OCEANIC-STROKE Primary Results Infographic

OCEANIC-STROKE_Primary Results_Infographic(EN).pdf

OCEANIC-STROKE Primary Results Infographic (EN)

OCEANIC-STROKE Primary Results

OCEANIC-STROKE Phase III Study Overview Slidedeck

MA-M_ASUN-CA-0001-2_OCEANIC-STROKE_Ph3_overview(EN)_V2.pptx

OCEANIC-STROKE Study Overview

FXIa Pathway and PK-PD

MA-M_ASUN-CA-0017-1-MDT3-4 - FXIa pathway and PK-PD.pptx

New Findings: Latest Conference Posters &amp; Presentations

New Findings: Latest Conference Posters & Presentations

Third-Party Learning Material (OCEANIC-STROKE)

Third Party Learning Material (OCEANIC-STROKE)

Factor XIa Inhibitor Mechanism of Action

Ask a Question

OCEANIC-STROKE

Phase III study of asundexian, an oral FXIa inhibitor, for the prevention of secondary stroke

OCEANIC-STROKE

Slide Decks

Additional

Factor XIa Inhibitor Mechanism of Action